Pancreatic cancer is a deadly disease with a dismal prognosis. However, recent advances in sequencing and bioinformatic technology have led to the systematic characterization of the genomes of all major tumor types in the pancreas. This characterization has revealed the unique genomic landscape of each tumor type. This knowledge will pave the way for improved diagnostic and therapeutic approaches to pancreatic tumors that take advantage of the genetic alterations in these neoplasms.
Citations
Citations to this article as recorded by
Research of immunotherapy in pancreatic cancer Zetian Li, Y.-T. Yu, P.P. Piccaluga, S. Xie BIO Web of Conferences.2024; 111: 02026. CrossRef
c-Myc inhibition and p21 modulation contribute to unsymmetrical bisacridines-induced apoptosis and senescence in pancreatic cancer cells Agnieszka Kurdyn, Monika Pawłowska, Ewa Paluszkiewicz, Mirosława Cichorek, Ewa Augustin Pharmacological Reports.2024;[Epub] CrossRef
Imaging phenotype using 18F-fluorodeoxyglucose positron emission tomography–based radiomics and genetic alterations of pancreatic ductal adenocarcinoma Chae Hong Lim, Young Seok Cho, Joon Young Choi, Kyung-Han Lee, Jong Kyun Lee, Ji Hye Min, Seung Hyup Hyun European Journal of Nuclear Medicine and Molecular Imaging.2020; 47(9): 2113. CrossRef
NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS Mitali Chattopadhyay, Ravinder Kodela, Gabriela Santiago, Thuy Tien C. Le, Niharika Nath, Khosrow Kashfi Biochemical Pharmacology.2020; 176: 113857. CrossRef
Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising? Friederike Inga Nollmann, Dietrich Alexander Ruess Biomedicines.2020; 8(8): 281. CrossRef
Ancillary Techniques in Cytologic Specimens Obtained from Solid Lesions of the Pancreas: A Review Jonas J. Heymann, Momin T. Siddiqui Acta Cytologica.2020; 64(1-2): 103. CrossRef
DNA polymerase η mutational signatures are found in a variety of different types of cancer Igor B. Rogozin, Alexander Goncearenco, Artem G. Lada, Subhajyoti De, Vyacheslav Yurchenko, German Nudelman, Anna R. Panchenko, David N. Cooper, Youri I. Pavlov Cell Cycle.2018; 17(3): 348. CrossRef
Genetics of Pancreatic Neoplasms and Role of Screening Venkata S. Katabathina, Omid Y. Rikhtehgar, Anil K. Dasyam, Rohan Manickam, Srinivasa R. Prasad Magnetic Resonance Imaging Clinics of North America.2018; 26(3): 375. CrossRef
Team work and cytopathology molecular diagnosis of solid pancreatic lesions Carlo Fabbri, Giulia Gibiino, Adele Fornelli, Vincenzo Cennamo, Daniela Grifoni, Michela Visani, Giorgia Acquaviva, Matteo Fassan, Sirio Fiorino, Silvia Giovanelli, Marco Bassi, Stefania Ghersi, Giovanni Tallini, Elio Jovine, Antonio Gasbarrini, Dario de Digestive Endoscopy.2017; 29(6): 657. CrossRef
Mutational signatures and mutable motifs in cancer genomes Igor B. Rogozin, Youri I. Pavlov, Alexander Goncearenco, Subhajyoti De, Artem G. Lada, Eugenia Poliakov, Anna R. Panchenko, David N. Cooper Briefings in Bioinformatics.2017;[Epub] CrossRef
The evolving field of genomic biomarkers to characterize pancreatic cystic neoplasia by EUS-guided FNA Ferga C. Gleeson, Michael J. Levy Gastrointestinal Endoscopy.2016; 83(1): 149. CrossRef
MIA PaCa-2 and PANC-1 – pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors Rui Gradiz, Henriqueta C. Silva, Lina Carvalho, Maria Filomena Botelho, Anabela Mota-Pinto Scientific Reports.2016;[Epub] CrossRef
p53 and p16/p19 Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells Stephanie Azzopardi, Sharon Pang, David S. Klimstra, Yi-Chieh Nancy Du Neoplasia.2016; 18(10): 610. CrossRef
MicroRNA-506 participates in pancreatic cancer pathogenesis by targeting PIM3 JUNDONG DU, XI ZHENG, SHOUWANG CAI, ZIMAN ZHU, JINGWANG TAN, BIN HU, ZHIQIANG HUANG, HUABO JIAO Molecular Medicine Reports.2015; 12(4): 5121. CrossRef